Sage Journals: Discover world-class research

Retricted access

Review article

First published 2018-1

The Clinical Use of a Fixed-Dose Combination of Insulin Degludec and Liraglutide (Xultophy 100/3.6) for the Treatment of Type 2 Diabetes

Kira Harris, Kimberly Lovin Nealy

Annals of Pharmacotherapy

Retricted access

Review article

First published 2017-5

Insulin Degludec/Liraglutide

Danial E. Baker

Hospital Pharmacy

Open access

Research article

First published 2016-3

IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test

Jens J. Holst, John B. Buse, Helena W. Rodbard [...]

Journal of Diabetes Science and Technology

Retricted access

Research article

First published 2017-04

A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges

Allen B. King, Athena Philis-Tsimikas, Eric S. Kilpatrick [...]

Diabetes Technology & Therapeutics

Retricted access

Review article

First published 2019-8

Combined Insulin and GLP-1 Receptor Agonists: Simplifying Treatment or Adding Obstacles?

Tianrui Yang, B. Tate Cutshall, Alexandra Tatara [...]

Journal of Pharmacy Practice

Free access

Research article

First published 2021-5

The Benefit of Insulin Degludec/Liraglutide (IDegLira) Compared With Basal-Bolus Insulin Therapy is Consistent Across Participant Subgroups With Type 2 Diabetes in the DUAL VII Randomized Trial

Liana K. Billings, Bue F. Ross Agner, Yuksel Altuntas [...]

Journal of Diabetes Science and Technology

Free access

Review article

First published 2018-5

The role of basal insulin and GLP-1 receptor agonist combination products in the management of type 2 diabetes

Taylor R. Inman, Erika Plyushko, Nicholas P. Austin [...]

Therapeutic Advances in Endocrinology and Metabolism

Retricted access

Research article

First published 2017-3

Bezlotoxumab

Danial E. Baker

Hospital Pharmacy

Retricted access

Review article

First published 2019-12

Efficacy and Safety of Basal Insulin/GLP-1 Receptor Agonist Used in Combination for Type 2 Diabetes Management

Delilah McCarty, Alaina Olenik, Bryan P. McCarty

Journal of Pharmacy Practice

Open access

Research article

First published 2025-7

Real-World Comparative Evaluation of Clinical and Economic Outcomes of Fixed-Ratio GLP-1 Receptor Agonist and Basal Insulin Combinations

Kevin Cowart, Troy Quast, Nicholas W. Carris

Diabetes Technology and Obesity Medicine

Search results